跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Bemiparin Sodium Injection
Approved
化学药品
Bemiparin Sodium Injection
LABORATORIOS FARMACEUTICOS ROVI SA
🇨🇳 National Medical Products Administration
Approval Date
Mar 5, 2020
Approval ID
7MazXbEVBHg
Company
LABORATORIOS FARMACEUTICOS ROVI SA
Type
化学药品
Approval Details
Approval Id
7MazXbEVBHg
Approval Number
H20140019
Generic Name
贝米肝素钠注射液
Generic Name En
Bemiparin Sodium Injection
Trade Name
稀保
Brand Name
稀保
Drug Type
化学药品
Dosage Form
注射剂
Strength
0.2ml:3500IU(抗Xa)
Reg Date
2020-03-05
Expired Date
2025-03-04
Company Name
LABORATORIOS FARMACEUTICOS ROVI SA
Company Address
Julian Camarillo,35 28037 Madrid, Spain
Production Company Name
rovi pharma industrial services, s.a.
Production Company Address
Julián Camarillo,35-28037 MADRID, SPAIN
Company Detail Path
/organization/laboratorios-farmaceuticos-rovi-sa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 5, 2020
Approval ID
7MazXbEVBHg
Type
化学药品
Back to NMPA Approvals
稀保 - NMPA Drug Approval Details